Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ebiom.2016.01.017 http://scihub22266oqcxt.onion/10.1016/j.ebiom.2016.01.017 C4776061!4776061!26981569     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       EBioMedicine 2016 ; 4 (ä): 26-39 Nephropedia Template TP {{tp|p=26981569|t=2016. Emerging Tools for Stroke Prevention in Atrial Fibrillation |pdf=|usr=}}{{26981569}} gab.com Text Emerging Tools for Stroke Prevention in Atrial Fibrillation JO: EBioMedicine http://www.kidney.de/pget.php?&tw=1&pmid=26981569 #FOAvip Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile. Twit Text FOAVip Emerging Tools for Stroke Prevention in Atrial Fibrillation ????EBioMedicine http://www.kidney.de/pget.php?&tw=1&pmid=26981569 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26981569 #FOAvip English Wikipedia <ref>{{Cite pmid|26981569}}</ref> Emerging Tools for Stroke Prevention in Atrial Fibrillation #MMPMID26981569 Voukalis C; Lip GY; Shantsila E EBioMedicine 2016[Feb]; 4 (ä): 26-39 PMID26981569show ga Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile. äEmerging Tools for Stroke Prevention in Atrial Fibrillation (epmc).pdf DeepDyve Pubget Overpricing